Insider Trackers: October 13-17, 2025

In partnership with

The Tech newsletter for Engineers who want to stay ahead

Tech moves fast, but you're still playing catch-up?

That's exactly why 100K+ engineers working at Google, Meta, and Apple read The Code twice a week.

Here's what you get:

• Curated tech news that shapes your career - Filtered from thousands of sources so you know what's coming 6 months early.

• Practical resources you can use immediately - Real tutorials and tools that solve actual engineering problems.

• Research papers and insights decoded - We break down complex tech so you understand what matters.

All delivered twice a week in just 2 short emails.

Join 100K+ engineers

💰 TOP INSIDER TRADES

TransDigm Group (TDG) dominated the week's activity with 13 separate transactions totaling $3.8 million. Director W. Nicholas Howley executed multiple sales at prices ranging from $1,294 to $1,299 per share, offloading over 1,400 shares in structured dispositions. The largest single sale moved 607 shares for $787,000. This is classic portfolio management from a long-tenured director—TDG shares have been on a tear, and Howley is systematically harvesting gains. These appear to be 10b5-1 programmed sales, the kind of pre-scheduled diversification that means nothing about the company's near-term prospects. TransDigm remains a compounding machine in aerospace components, and this selling is noise, not signal.

UWM Holdings (UWMC) saw its largest transaction of the week when Mat Ishbia, the company's CEO and major shareholder, sold 596,356 shares at $5.38 for $3.2 million on October 14. Ishbia wears multiple hats—director, 10% owner, and CEO—and maintains massive exposure to the mortgage lender's fortunes. At this scale, a $3.2 million sale is a rounding error for someone of Ishbia's net worth and stake size. This reads as routine liquidity management rather than a bearish thesis change, particularly given the modest per-share price and his continued substantial ownership post-transaction.

United Therapeutics (UTHR) CEO Martine Rothblatt executed a series of option exercises and paired sales totaling $2.7 million. Rothblatt exercised 8,000 options at a strike price of $120.26 and immediately sold 7,154 shares at prices around $430-$431, netting approximately $2.2 million after the exercise cost. This is textbook executive compensation monetization—exercising vested options and selling just enough to cover taxes and generate cash, while still retaining meaningful upside. The biotech has been a strong performer, and these transactions reflect compensation structure, not conviction change. Rothblatt remains deeply aligned with shareholders through substantial retained holdings.

Lightbridge Corporation (LTBR) President and CEO Seth Grae moved $1.7 million through a combination of option exercise and immediate sale. Grae exercised 32,296 options at $12.60 and sold the same number of shares at $28.07, realizing a $907,000 gain on the sale while covering the $407,000 exercise cost. The nuclear fuel technology company has seen volatility, and Grae is locking in gains on vested compensation. Like Rothblatt's moves at UTHR, this is liquidity management tied to option vesting schedules rather than a statement about LTBR's business trajectory.

MongoDB (MDB) director Dwight Merriman sold 2,000 shares at $322 for $644,000 on October 16. Merriman is a company founder and long-time board member with deep knowledge of the database software leader. The sale appears clean and straightforward—likely part of a 10b5-1 plan given the round lot size and precise execution. MDB has been consolidating after a strong run, and this looks like routine diversification from a director who's been along for the entire ride. Not a red flag.

Yelp (YELP) saw one of the week's few bright spots: an open-market purchase. While specific details on the buyer and size weren't prominent in the top transactions, this stands out as the only genuine display of insider conviction in the entire three-day period. In a sea of programmed sales and option exercises, actual cash deployed into shares is the rarest commodity—and the only type of transaction that truly matters for forward-looking investors.

🌊 SECTOR THEMES

Industrials: Volume Without Conviction
TransDigm's 13 transactions gave Industrials the week's highest activity count, but this was entirely director selling at all-time high prices. When a sector's insider activity is dominated by one company's systematic profit-taking, it's not a thematic signal—it's one person's tax planning. The aerospace and defense complex remains strong on fundamentals, but insiders aren't adding exposure at these levels. That's a statement about valuation, not business quality.

Healthcare: Option Exercise Theater
United Therapeutics and Lightbridge accounted for nine transactions in Healthcare, but strip away the option exercises and we're left with pure compensation liquidation. Both CEOs exercised options and immediately sold shares, capturing gains on vested equity while reducing exposure. This is the insider trading equivalent of background noise—legally required disclosures that tell us nothing about their companies' competitive positions or pipeline progress. Biotech has been choppy, and these executives are doing what executives do: converting paper gains to cash when the window opens.

Technology: One Director, One Sale
MongoDB's Merriman sale was Technology's only appearance this week. For a sector that's supposed to be leading the next wave of innovation—AI infrastructure, cloud migration, data analytics—the complete absence of insider buying is notable. Directors and executives in tech aren't putting personal capital to work in their own companies. Either they think valuations are full, or they're too busy selling into strength to consider adding. Neither interpretation is bullish.

The Missing Cluster: Financial Services and Communications
UWM and Yelp made token appearances, but the broader financial and communications sectors were essentially absent from meaningful insider activity. When entire sectors vanish from the filing flow, it typically means one of two things: insiders are in blackout windows ahead of earnings, or there's simply nothing compelling enough to act on. Given the timing—mid-October, ahead of the heavy earnings calendar—blackouts are the likely culprit. We'll watch for activity to resume in early November once reporting is complete.

Silence Is a Signal: The Buying Drought
The week's most important theme is what didn't happen. Only one open-market purchase across 31 transactions and 10 companies. Insiders aren't betting on their own businesses. When executives see their stock as undervalued or poised for a catalyst, they buy. When they see it as fairly valued or expensive, they sell through 10b5-1 plans and stay quiet. This week was nearly unanimous: selling and silence. The people with the best information are not deploying personal capital. That's not a market timing call, but it's certainly not a vote of confidence.

💡 INVESTOR TAKEAWAYS

• Separate signal from noise: The vast majority of this week's filings were structured sales, option exercises, and compensation grants. These are pre-programmed, tax-driven, or contractually obligated—not reflections of insider sentiment about business prospects.

• One purchase matters more than 20 sales: The lone open-market buy at Yelp is the week's only transaction that signals potential conviction. Everything else was executives managing wealth, not making bets.

• High-quality companies, routine selling: TransDigm, United Therapeutics, and MongoDB are solid businesses. The insider selling this week doesn't change that. Directors and CEOs with large positions naturally diversify. The absence of buying is more concerning than the presence of structured selling.

• Watch the calendar: Mid-October blackout windows suppress activity. The real test comes in early November when earnings are out and insiders can trade freely. If open-market buying remains absent even after the blackout lifts, that's when the silence becomes deafening.

• Valuation matters: When insiders consistently sell and never buy, they're telling you something about price. It doesn't mean sell your positions, but it does mean temper your expectations for near-term multiple expansion.

👀 WATCHLIST

Yelp (YELP) – The week's only open-market purchase makes this worth monitoring. If more insiders follow with buying, it could signal management sees value at current levels. Watch for additional Form 4 filings in the next two weeks.

TransDigm Group (TDG) – After 13 sales from director Howley, watch whether other insiders or the company itself step in as buyers if shares pull back. TDG has a history of aggressive buybacks; any dip could be met with corporate support.

United Therapeutics (UTHR) – Rothblatt's option exercises are done for now, but watch for open-market purchases if the stock corrects. CEO buying after a pullback would be a strong signal; continued option-and-sell cycles are neutral.

MongoDB (MDB) – Merriman's sale clears out some overhang. If other directors or executives buy on weakness, it would mark a shift from diversification to conviction. MDB's fundamentals remain strong; insider buying would confirm management's confidence.

Lightbridge (LTBR) – Small-cap nuclear plays are volatile. CEO Grae locked in gains, which is prudent after a run. Watch for any follow-on purchases if shares stabilize or dip—that would indicate he's done selling and ready to add.

👋 CLOSING NOTES

This week's insider activity was a case study in what not to read into filings. Structured sales, option exercises, and compensation grants dominated the landscape, while genuine open-market conviction was nearly invisible. That doesn't mean the market is broken or these companies are in trouble—it simply means insiders are managing their personal balance sheets, not making bold bets.

The takeaway for investors is clear: when the people who know their businesses best aren't buying, you should be cautious about overpaying. The absence of insider purchases doesn't tell you to sell, but it does tell you to be patient, disciplined, and selective. Wait for better entry points. Wait for insiders to put their own money where their mouths are.

As we head into the heart of earnings season, watch for the blackout windows to lift and insider activity to resume. If open-market buying remains absent even after reporting clears, that's when the silence becomes a statement. For now, it's noise. But noise can become a pattern—and patterns matter.

Disclaimer: This newsletter is for informational purposes only and does not constitute investment advice. Insider transactions can occur for many reasons unrelated to company prospects, including personal financial planning, diversification, and tax management. Always conduct your own research and consult with a financial advisor before making investment decisions. Past performance does not guarantee future results.